halozyme posts
FeedPosted Nov 2nd 2007 3:00PM by Eric Buscemi (RSS feed)
Filed under: Earnings reports, Forecasts, Conventions and conferences, Annual meetings, Yahoo! (YHOO), Wal-Mart (WMT), Walt Disney (DIS), Gap Inc (GPS), Abercrombie and Fitch (ANF), Burger King Hldgs (BKC), Goldcorp Inc (GG)
.gif)
Monday, November 5
Tuesday, November 6
- Merrill Lynch to host conference call discussing Focus Media's (NASDAQ: FMCN) secondary offering at 11am.
- Yahoo (NASDAQ: YHOO) CEO Jerry Yang, Senior VP Michael Callahan & General Counsel to testify before the House Foreign Affairs Committee on how their company gave false information to Congress relating to their role in a human rights case in China which resulted in a journalist being sent to jail for 10 years.
Wednesday, November 7
Thursday, November 8
Friday, November 9
Posted Jul 24th 2007 11:11AM by Kevin Shult (RSS feed)
Filed under: Analyst reports, MasterCard Inc'A' (MA), U.S. Steel (X), Analyst initiations
MOST NOTEWORTHY: Halozyme Therapeutics (HALO), Rosetta Genomics (ROSG), U.S. Steel (X) and BioFuel Energy (BIOF) were today's noteworthy initiations:
- Halozyme (NASDAQ: HALO) was initiated with a Buy rating and $14 target at Oppenheimer. The firm is positive on Halozyme's prospects for signing additional multi-product Enhanze deals in the next 12 months and the company's expanding internal pipeline.
- Oppenheimer also initiated shares of Rosetta Genomics (NASDAQ: ROSG) with a Buy rating and $11 target, as the firm is positive on Rosetta's intellectual property position in the emerging microRNA field related to the development and commercialization of research, diagnostic and therapeutic products, and other applications.
- BioFuel Energy (NASDAQ: BIOF) was initiated with a Neutral rating at Cowen, as the firm sees a lack of catalysts until the company's plants under construction come on line in Q108...
OTHER INITIATIONS:
- Brightpoint (NASDAQ: CELL) was initiated with an Outperform rating and $18 target at Credit Suisse.
- MasterCard (NYSE: MA) was initiated with a Market Perform rating at Wachovia on valuation.
Analyst summaries provided by TheFlyOnTheWall.com (subscription required).